Surmounting structural barriers to tackle endemic infectious diseases. Academic Article uri icon

Overview

abstract

  • A unique experiment in bringing academic and industrial scientists together to tackle endemic infectious diseases has proved a success. The Tres Cantos Open Lab Foundation, guided and advised by independent experts, funds extended stays of academics at the campus of a pharmaceutical company, where they access the firm's resources in partnership with company scientists. Progress in tackling tuberculosis, protozoal infections, and enteric bacterial diseases has sustained the decade-long evolution of the model, whose distinctive features complement other public-private partnerships with similar goals.

publication date

  • August 19, 2021

Research

keywords

  • Communicable Diseases
  • Drug Development
  • Drug Industry
  • Endemic Diseases

Identity

PubMed Central ID

  • PMC8383816

Scopus Document Identifier

  • 85114659455

Digital Object Identifier (DOI)

  • 10.1084/jem.20211418

PubMed ID

  • 34410327

Additional Document Info

volume

  • 218

issue

  • 9